Sagimet Biosciences Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Sagimet Biosciences Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Sagimet Biosciences Inc - Ordinary Shares - Class A
Rating: 1.69558325
Author: Trendlyne DVM scores

about

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolis...

7.51 -0.05 (-0.66%)

34.18% Fall from 52W High

378.0K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Sagimet Biosciences Inc - Ordinary Shares - Class A is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference See details